Geode Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51M | Sell |
|
|||||
|
2025
Q1 | $47.9M | Buy |
|
|||||
|
2024
Q4 | $75.7M | Buy |
|
|||||
|
2024
Q3 | $118M | Buy |
|
|||||
|
2024
Q2 | $98.6M | Sell |
|
|||||
|
2024
Q1 | $191M | Buy |
|
|||||
|
2023
Q4 | $39.6M | Buy |
|
|||||
|
2023
Q3 | $22.4M | Buy |
|
|||||
|
2023
Q2 | $29.9M | Buy |
|
|||||
|
2023
Q1 | $14.4M | Buy |
|
|||||
|
2022
Q4 | $6.15M | Buy |
|
|||||
|
2022
Q3 | $1.78M | Sell |
|
|||||
|
2022
Q2 | $1.98M | Sell |
|
|||||
|
2022
Q1 | $3.88M | Buy |
|
|||||
|
2021
Q4 | $5.43M | Sell |
|
|||||
|
2021
Q3 | $7.46M | Buy |
|
|||||
|
2021
Q2 | $6.95M | Buy |
|
|||||
|
2021
Q1 | $6.73M | Buy |
|
|||||
|
2020
Q4 | $5.48M | Buy |
|
|||||
|
2020
Q3 | $5.52M | Sell |
|
|||||
|
2020
Q2 | $7.07M | Buy |
|
|||||
|
2020
Q1 | $4.53M | Buy |
|
|||||
|
2019
Q4 | $7.29M | Buy |
|
|||||
|
2019
Q3 | $5.42M | Buy |
|
|||||
|
2019
Q2 | $6.14M | Buy |
|
|||||
|
2019
Q1 | $6.69M | Buy |
|
|||||
|
2018
Q4 | $4.55M | Buy |
|
|||||
|
2018
Q3 | $7.93M | Buy |
|
|||||
|
2018
Q2 | $3.76M | Buy |
|
|||||
|
2018
Q1 | $1.02M | Buy |
|
|||||
|
2017
Q4 | $477K | Buy |
|
|||||
|
2017
Q3 | $59K | Hold |
|
|||||
|
2017
Q2 | $33K | Hold |
|
|||||
|
2017
Q1 | $45K | Hold |
|
|||||
|
2016
Q4 | $37K | Hold |
|
|||||
|
2016
Q3 | $44K | Hold |
|
|||||
|
2016
Q2 | $39K | Buy |
|